aminoglycoside therapy (N = 319)

no aminoglycoside therapy (N = 96)

p value

Cardiovascular disease

0.079

no

270 (84.6%)

88 (91.7%)

yes

49 (15.4%)

8 (8.3%)

Lung disease

0.968

no

306 (95.9%)

92 (95.8%)

yes

13 (4.1%)

4 (4.2%)

Kidney disease

0.583

no

318 (99.7%)

96 (100.0%)

yes

1 (0.3%)

0 (0.0%)

Neurological disease

0.200

no

317 (99.4%)

94 (97.9%)

yes

2 (0.6%)

2 (2.1%)

Immobility

0.200

no

317 (99.4%)

94 (97.9%)

yes

2 (0.6%)

2 (2.1%)

Cancer

0.437

no

317 (99.4%)

96 (100.0%)

yes

2 (0.6%)

0 (0.0%)

Diabetes type 2

0.096

no

310 (97.2%)

96 (100.0%)

yes

9 (2.8%)

0 (0.0%)

Other diseases

0.894

no

284 (89.0%)

85 (88.5%)

yes

35 (11.0%)

11 (11.5%)

ASA score

0.275

I

169 (53.8%)

58 (61.1%)

II

118 (37.6%)

34 (35.8%)

III

24 (7.6%)

3 (3.2%)

IV

3 (1.0%)

0 (0.0%)

Complications

0.561

no

268 (84.0%)

83 (86.5%)

yes

51 (16.0%)

13 (13.5%)